Mahoney Michael F
SEC CIK 1533022 · EDGAR
BoughtSold
Most active insiders at BSX, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Mahoney Michael F | COB, Pres, CEO, Dir | $9.00M | $15.04M |
| 2 | Fitzgerald Joseph Michael | EVP, Group Pres, Cardiology | — | $9.90M |
| 3 | Zane Ellen M | Dir | — | $2.57M |
| 4 | Butcher Arthur C | EVP, Grp Pres, MedSurg, APAC | — | $1.76M |
| 5 | LUDWIG EDWARD J | Dir | $430.3K | — |
| 6 | Habiger David C | Dir | $407.9K | — |
| 7 | Morano Susan E | Dir | $100.4K | — |
| 8 | Pegus Cheryl | Dir | $100.0K | — |
| 9 | O'Connor Padraig Andrew | EVP, Gbl Ops | — | — |
| 10 | O'Sullivan Miriam | SVP, Chief HR Off | — | — |
Transactions 96
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-08-05 16:15 | 2026-08-03 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | P - Purchase | $48.33 | +186.2K | 1.59M | +13% | +$9.00M | |
| I | 2026-08-05 16:15 | 2026-08-03 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | I - Discretionary | $48.43 | +22.1K | 22.1K | New | +$1.07M |
| I | 2026-06-01 16:18 | 2026-05-28 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -386.8K | 0 | -100% | $0 |
| DM | 2026-02-18 | 2026-02-13+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +41.6K | 1.69M | +3% | $0 |
| DM | 2026-02-18 | 2026-02-13+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $74.73 | -148.0K | 1.57M | -9% | -$11.06M |
| DM | 2026-02-18 | 2026-02-13 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | A - Grant | $0.00 | +264.4K | 1.68M | +19% | $0 |
| D | 2026-02-17 | 2026-02-12 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $74.12 | -6,626 | 1.42M | -0.5% | -$491.1K |
| D | 2026-02-17 | 2026-02-12 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +13.7K | 1.43M | +1.0% | $0 |
| DM | 2026-02-03 | 2026-02-02 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $25.78 | +95.8K | 1.57M | +6% | +$2.47M |
| DM | 2026-02-03 | 2026-02-02 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $93.49 | -160.9K | 1.57M | -9% | -$15.04M |
| MI | 2025-10-31 | 2025-10-29+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | +12.2K | 363.7K | +3% | $0 |
| DM | 2025-06-03 | 2025-06-02 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $103.69 | -164.4K | 1.57M | -9% | -$17.05M |
| DM | 2025-06-03 | 2025-06-02 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $20.67 | +105.6K | 1.64M | +7% | +$2.18M |
| D | 2025-05-19 | 2025-05-15 | CVS | CVS Health | Mahoney Michael F | Dir | A - Grant | $60.47 | +144 | 6,345 | +2% | +$8,708 |
| DM | 2025-05-05 | 2025-05-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $102.48 | -164.4K | 1.63M | -9% | -$16.85M |
| DM | 2025-05-05 | 2025-05-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $20.67 | +105.6K | 1.65M | +7% | +$2.18M |
| D | 2025-04-02 | 2025-04-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $100.01 | -164.4K | 1.59M | -9% | -$16.45M |
| DM | 2025-04-02 | 2025-04-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $20.67 | +105.6K | 1.71M | +7% | +$2.18M |
| 2025-02-19 | 2025-02-18 | CVS | CVS Health | Mahoney Michael F | Dir | P - Purchase | $66.70 | +30.0K | 39.4K | +321% | +$2.00M | |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +51.1K | 1.64M | +3% | $0 |
| DM | 2025-02-18 | 2025-02-14+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $106.11 | -24.7K | 1.65M | -1% | -$2.62M |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +13.7K | 1.63M | +0.8% | $0 |
| D | 2025-02-14 | 2025-02-12 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $105.77 | -6,626 | 1.63M | -0.4% | -$700.8K |
| 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $105.98 | -62.9K | 1.62M | -4% | -$6.67M | |
| 2025-02-13 | 2025-02-11 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | A - Grant | $0.00 | +130.1K | 1.68M | +8% | $0 | |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +57.1K | 1.58M | +4% | $0 |
| D | 2025-01-03 | 2025-01-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $89.32 | -25.7K | 1.55M | -2% | -$2.29M |
| I | 2024-11-27 | 2024-11-26 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -7,800 | 201.5K | -4% | $0 |
| 2024-11-25 | 2024-11-21 | CVS | CVS Health | Mahoney Michael F | Dir | A - Grant | $57.10 | +2,200 | 6,201 | +55% | +$125.6K | |
| DM | 2024-11-07 | 2024-11-05 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $16.79 | +111.9K | 1.68M | +7% | +$1.88M |
| DM | 2024-11-07 | 2024-11-05 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $84.75 | -162.8K | 1.68M | -9% | -$13.79M |
| DM | 2024-10-08 | 2024-10-07 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $84.63 | -162.8K | 1.57M | -9% | -$13.78M |
| DM | 2024-10-08 | 2024-10-07 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $16.79 | +111.9K | 1.68M | +7% | +$1.88M |
| DM | 2024-09-06 | 2024-09-05 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $16.79 | +111.9K | 1.73M | +7% | +$1.88M |
| D | 2024-09-06 | 2024-09-05 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $81.17 | -162.8K | 1.62M | -9% | -$13.21M |
| MI | 2024-09-03 | 2024-08-30 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | +33.0K | 209.3K | +19% | $0 |
| 2024-05-17 | 2024-05-16 | CVS | CVS Health | Mahoney Michael F | Dir | A - Grant | $57.52 | +2,184 | 4,001 | +120% | +$125.6K | |
| 2024-05-02 | 2024-05-02 | CVS | CVS Health | Mahoney Michael F | Dir | P - Purchase | $54.49 | +9,181 | 9,356 | +5,246% | +$500.3K | |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +50.9K | 1.68M | +3% | $0 |
| DM | 2024-02-20 | 2024-02-16+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $65.82 | -22.6K | 1.66M | -1% | -$1.49M |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $65.95 | -7,328 | 1.65M | -0.4% | -$483.3K |
| D | 2024-02-16 | 2024-02-14 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +16.5K | 1.65M | +1% | $0 |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | A - Grant | $0.00 | +146.7K | 1.70M | +9% | $0 | |
| 2024-02-08 | 2024-02-06 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $0.00 | -65.0K | 1.64M | -4% | $0 | |
| D | 2024-01-02 | 2024-01-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +95.9K | 1.59M | +6% | $0 |
| D | 2024-01-02 | 2024-01-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $57.81 | -40.1K | 1.55M | -3% | -$2.32M |
| 2023-11-17 | 2023-11-15 | CVS | CVS Health | Mahoney Michael F | Dir | A - Grant | $69.13 | +1,817 | 1,817 | New | +$125.6K | |
| DM | 2023-11-07 | 2023-11-06 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $14.67 | +113.4K | 1.56M | +8% | +$1.66M |
| D | 2023-11-07 | 2023-11-06 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $52.51 | -113.4K | 1.50M | -7% | -$5.95M |
| D | 2023-10-10 | 2023-10-09 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $52.09 | -113.4K | 1.50M | -7% | -$5.90M |
| DM | 2023-10-10 | 2023-10-09 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $14.67 | +113.4K | 1.61M | +8% | +$1.66M |
| DM | 2023-09-12 | 2023-09-12 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $14.67 | +113.4K | 1.61M | +8% | +$1.66M |
| D | 2023-09-12 | 2023-09-12 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $53.91 | -113.4K | 1.50M | -7% | -$6.11M |
| MI | 2023-09-01 | 2023-08-30+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | +142.5K | 175.2K | +437% | $0 |
| 2023-09-01 | 2023-08-30 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -318.2K | 1.50M | -18% | $0 | |
| 2023-05-04 | 2023-05-02 | BAX | Baxter International | Mahoney Michael F | Dir | A - Grant | $0.00 | +4,573 | 9,692 | +89% | $0 | |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +16.8K | 1.86M | +0.9% | $0 |
| D | 2023-02-22 | 2023-02-21 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $46.23 | -7,462 | 1.85M | -0.4% | -$345.0K |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +50.9K | 1.84M | +3% | $0 |
| DM | 2023-02-21 | 2023-02-16+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $46.52 | -22.6K | 1.82M | -1% | -$1.05M |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $47.29 | -8,186 | 1.81M | -0.4% | -$387.1K |
| D | 2023-02-16 | 2023-02-15 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +18.5K | 1.82M | +1% | $0 |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $46.27 | -22.6K | 1.80M | -1% | -$1.04M |
| D | 2023-01-03 | 2023-01-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +57.8K | 1.83M | +3% | $0 |
| DM | 2022-11-08 | 2022-11-07 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $9.35 | +125.8K | 1.85M | +7% | +$1.18M |
| D | 2022-11-08 | 2022-11-07 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $41.97 | -125.8K | 1.77M | -7% | -$5.28M |
| DM | 2022-10-04 | 2022-10-03 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $9.35 | +125.8K | 1.85M | +7% | +$1.18M |
| D | 2022-10-04 | 2022-10-03 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $39.34 | -125.8K | 1.77M | -7% | -$4.95M |
| D | 2022-09-07 | 2022-08-30 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -365.5K | 1.77M | -17% | $0 |
| DM | 2022-09-07 | 2022-09-06 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $9.35 | +125.8K | 1.89M | +7% | +$1.18M |
| D | 2022-09-07 | 2022-09-06 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $40.49 | -125.8K | 1.77M | -7% | -$5.09M |
| D | 2022-08-09 | 2022-08-08 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $40.97 | -125.8K | 2.13M | -6% | -$5.16M |
| DM | 2022-08-09 | 2022-08-08 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $9.35 | +125.8K | 2.22M | +6% | +$1.18M |
| 2022-05-05 | 2022-05-03 | BAX | Baxter International | Mahoney Michael F | Dir | A - Grant | $0.00 | +2,706 | 5,004 | +118% | $0 | |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $44.17 | -8,130 | 2.13M | -0.4% | -$359.1K |
| D | 2022-03-02 | 2022-02-28 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +18.3K | 2.14M | +0.9% | $0 |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $42.55 | -7,462 | 2.12M | -0.4% | -$317.5K |
| D | 2022-02-23 | 2022-02-21 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +16.8K | 2.13M | +0.8% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +34.6K | 2.11M | +2% | $0 |
| DM | 2022-02-22 | 2022-02-17+ | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $42.70 | -15.4K | 2.11M | -0.7% | -$656.0K |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $44.01 | -8,186 | 2.09M | -0.4% | -$360.3K |
| D | 2022-02-17 | 2022-02-15 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +18.5K | 2.10M | +0.9% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $0.00 | +60.6K | 2.11M | +3% | $0 |
| D | 2022-01-03 | 2021-11-12 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -34.9K | 2.05M | -2% | $0 |
| D | 2022-01-03 | 2022-01-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | F - Tax | $42.48 | -23.5K | 2.08M | -1% | -$1.00M |
| DM | 2021-11-02 | 2021-11-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $6.64 | +201.0K | 2.28M | +10% | +$1.34M |
| D | 2021-11-02 | 2021-11-01 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $43.05 | -201.0K | 2.08M | -9% | -$8.65M |
| DM | 2021-10-05 | 2021-10-04 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $6.64 | +201.0K | 2.22M | +10% | +$1.34M |
| DM | 2021-10-05 | 2021-10-04 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $42.92 | -201.0K | 2.08M | -9% | -$8.63M |
| DM | 2021-09-08 | 2021-09-07 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $6.64 | +201.0K | 2.22M | +10% | +$1.34M |
| D | 2021-09-08 | 2021-09-07 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $44.57 | -201.0K | 2.08M | -9% | -$8.96M |
| DM | 2021-08-04 | 2021-08-02 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $6.64 | +201.0K | 2.22M | +10% | +$1.34M |
| D | 2021-08-04 | 2021-08-02 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $45.74 | -201.0K | 2.08M | -9% | -$9.20M |
| D | 2021-07-08 | 2021-05-14 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | G - Gift | $0.00 | -35.0K | 2.08M | -2% | $0 |
| D | 2021-07-08 | 2021-07-06 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | S - Sale+OE | $43.41 | -201.0K | 2.08M | -9% | -$8.73M |
| DM | 2021-07-08 | 2021-07-06 | BSX | Boston Scientific | Mahoney Michael F | COB, Pres, CEO, Dir | M - OptEx | $6.64 | +201.0K | 2.22M | +10% | +$1.34M |
Purchase Sale Sale after option exercise All abbreviations